Implementing the Medicare $2 drug list model would have reduced out-of-pocket spending by 63% for Part D beneficiaries in 2021. The model caps cost-sharing at $2 for a 30-day supply of 101 generic ...
As the cost of branded drugs is increasing faster than ever, challenging the purchasing power of patients, the demand for generic medicines is on the rise. Generic medicines, the patent-expired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results